Kolexia
Zerbit Jérémie Pharmacien
Zerbit Jérémie
Pharmacien
Hospitalisation A Domicile Aphp Paris
Paris, France
160 Activités
6.3 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Lymphomes Leucémies Tumeurs hématologiques Syndrome de perfusion du propofol Leucémie aigüe myéloïde Tumeurs de la thyroïde Lymphome B Leucémie myéloïde

Collaborateurs

Voir plus
Bouscary Didier
Bouscary Didier
Hôpital Cochin, Paris, France
Batista Rui
Batista Rui
Hôpital Cochin, Paris, France
Willems Lise
Willems Lise
Hôpital Cochin, Paris, France
Decroocq Justine
Decroocq Justine
Hôpital Cochin, Paris, France

Industries

Voir plus
Novartis
10 collaboration(s)
Dernière en 2023
AstraZeneca
6 collaboration(s)
Dernière en 2023
Janssen
5 collaboration(s)
Dernière en 2023
Abbvie
3 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
RCHOP Plus High-Dose Methotrexate As First-Line Therapy in Large B-Cell Lymphoma with Testis Involvement
65th ASH Annual Meeting Abstracts   02 novembre 2023
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM).
Cancers   09 août 2023
PROGNOSTIC SCORING SYSTEMS FOR SEVERE CRS AND ICANS AFTER AUTOLOGOUS ANTI-CD19 CAR T CELLS IN LARGE B-CELL LYMPHOMA: A DESCAR-T REGISTRY STUDY FORM THE LYSA
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Venetoclax exposure-safety relationships in real life acute myeloid leukemia (AML) patients
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein.
Cell death discovery   17 mars 2023
Remdesivir for Patients Hospitalized with COVID-19 Severe Pneumonia: A National Cohort Study (Remdeco-19).
Journal of clinical medicine   04 novembre 2022
Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era.
Viruses   27 octobre 2022
Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis.
European journal of cancer care   23 octobre 2022
1023P Relationship between 18F-FDG PET colonic uptake, resting energy expenditure and immune checkpoint inhibitors efficacy in metastatic non-small cell lung cancer (NSCLC) patients: Preliminary results of the MICROBIO-TEP study
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
COVIMAB: A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Patients at High Risk of Severe Forms of Covid-19
Essai Clinique (Assistance publique – Hôpitaux de Paris)   05 juillet 2022